Emiliano Calvo Aller on ‘Pharmacology and Dose-Selection of ADCs’ at the ESMO2024 Oral Abstract Session
The START Center for Cancer Care shared on LinkedIn:
“Join START at the ESMO2024 Oral Abstract Session on ‘Current Advances in Clinical Pharmacology Within Oncology, And Its Relevance for Daily Practice,’ co-chaired by our President of Europe and Director of Clinical Research at START Madrid-CIOCC, Emiliano Calvo Aller, on Sunday, September 15, beginning at 16:30.
Dr. Calvo will provide insights on ‘Pharmacology and Dose-Selection of ADCs.’
Other topics in this session include therapeutic drug monitoring of kinase inhibitors, boosting studies to increase drug exposure of anticancer drugs, and the cost-effectiveness of optimized immunotherapy dosing.
We invite you to join us for this invigorating discussion!
Schedule a meeting with our PIs at ESMO to learn more about our innovative work in oncology research.”
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023